Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07278440 · ClinicalTrials.gov registry record · NA

An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregivers, ET-NEURO Trial

A NA study, sponsored by OHSU Knight Cancer Institute.

Not yet
Registry status
NA
Development phase
36
Enrollment target

NCT07278440: Clinical Trial NA study, sponsored by OHSU Knight Cancer Institute.

NCT07278440 is a NA study that has not yet begun recruiting, run by OHSU Knight Cancer Institute. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07278440, a NA study, has not yet begun recruiting, sponsored by OHSU Knight Cancer Institute.

NOT YET RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

This clinical trial evaluates the effects of a partnered exercise program, called Exercise Together, on participants with primary brain tumors and their caregivers. Standard treatments for primary brain tumors require extensive caregiver support, and both patients and caregivers experience high psychological distress and physical burden as a result. While exercise is known to improve outcomes in cancer patients, its impact on primary brain tumor patients and caregivers remains unstudied. Exercise Together is a supervised, group exercise program previously studied in patients with other types of cancer, though never in patients with primary brain tumors or their caregivers. Exercise Together uses functional resistance training to target muscle groups essential for everyday activities to improve daily functioning. Since exercises are done in a partnered format, Exercise Together is also designed to foster teamwork and strengthen the relationship between the patient and their caregiver. This program may be safe, feasible, and effective in improving the mental and physical health of primary brain tumor patients and their caregivers.

Primary Outcome

Feasibility will be evaluated using an enrollment rate of ≥ 50% of eligible patient-caregiver dyads. Continuous variables will be characterized by N, mean or median, standard deviation or interquartile range; and discrete variables will be characterized by frequencies and proportions with exact 95% confidence intervals, as appropriate.

Interventions

  • PROCEDURE Magnetic Resonance Imaging
  • OTHER Questionnaire Administration
  • OTHER Electronic Health Record Review
  • OTHER Resistance Training

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2026-02-28
Est. Completion 2026-08-02
Phase NA
OHSU Knight Cancer Institute

211 total trials

What is known before NCT07278440 opens enrollment

NCT07278440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 4 interventions - of which Magnetic Resonance Imaging is the first listed.

NCT07278440 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07278440 about?

NCT07278440 is a clinical study titled "An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregivers, ET-NEURO Trial". This clinical trial evaluates the effects of a partnered exercise program, called Exercise Together, on participants with primary brain tumors and their caregivers. Standard treatments for primary brain tumors require extensive caregiver support, and both patients and caregivers experience high psyc...

What is the current status of trial NCT07278440?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2026-02-28. Estimated completion is 2026-08-02.

What interventions are being tested in trial NCT07278440?

The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), Questionnaire Administration (OTHER), Electronic Health Record Review (OTHER), Resistance Training (OTHER).

Who is sponsoring clinical trial NCT07278440?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07278440's enrollment target sits among peer trials

36 1541st of 2000 higher than 437 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07278440, the US trial registry maintained by the National Library of Medicine. NCT07278440 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.